Form4insider filings, from the source

SEC Form 4 · accession 0001192482-18-000151

COLLEGIUM PHARMACEUTICAL, INC · COLL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alison B Fleming
Officer — Chief Technology Officer
Period of report
Apr 2, 2018
Accepted (ET)
Apr 4, 2018 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 2, 2018M4,225$0.28A53,541D
Common StockApr 2, 2018M3,917$0.28A57,458D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock option (right to purchase)F1$0.28Apr 2, 2018M4,225D—Mar 5, 2024Common Stock4,2250D
Stock option (right to purchase)F2$0.28Apr 2, 2018M3,917D—Mar 5, 2024Common Stock3,9170D

Explanation of responses